Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors

NCT00004242 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: fluorouracil
DRUG: gemcitabine hydrochloride
DRUG: oxaliplatin

Sponsor

National Cancer Institute (NCI)